Endocare Raises $15.6 Million

Endocare, a medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation along with vacuum technologies for erectile dysfunction, reported that it has completed a private placement of 5,635,378 newly issued shares of its common stock raising approximately $15.6 million in gross proceeds.

LifeSciencesWorld (http://www.lifesciencesworld.com/news/news-5164.htm)